In summary, our study indicated that LHX6EX(+12) isoform group was the key constituent of LHX6 in the promotion of cervical cancer cell growth, and thus may be a new biomarker and a precise therapeutic target for cervical cancer in the future. Here, LHX6 is linked to cervical carcinoma.